Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(30%)
Results Posted
17%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
1
10%
Ph phase_1
5
50%
Ph phase_2
4
40%

Phase Distribution

5

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
5(50.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (50.0%)
Phase 24 (40.0%)
Phase 31 (10.0%)

Trials by Status

completed660%
terminated110%
recruiting330%

Recent Activity

3 active trials
Showing 5 of 10
recruitingphase_3

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

NCT06612268
recruitingphase_2

A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

NCT06198712
completedphase_2

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

NCT05725902
completedphase_1

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

NCT07023029
completedphase_1

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

NCT06581627
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06612268Phase 3

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Recruiting
NCT06198712Phase 2

A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Recruiting
NCT05725902Phase 2

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

Completed
NCT07023029Phase 1

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Completed
NCT06581627Phase 1

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

Completed
NCT05568225Phase 2

A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

Terminated
NCT06336018Phase 1

A Research Study on Etavopivat in Participants With and Without Liver Disease

Completed
NCT06433661Phase 1

A Research Study of the Effect of Food on Etavopivat in Healthy Participants

Completed
NCT06813924Phase 1

A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

Completed
NCT05953584Phase 2

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Recruiting

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10